Dear Readers,

As partners for the upcoming Biologics World Korea 2013 conference, Pharmaceutical-Tech would like to share with you a great piece of content created by the team at IMAPAC (as a preview of the top level discussions to take place at the event).

Dennis Chan, Former Executive Director at B.C. Ministry of Health, Canada (who is a speaker at the event), in an exclusive interview, shared his views on the market situation and strategies on gaining reimbursement listings for biologic drugs in Canada, the impact of commoditization, how challenges can present opportunities for biologics drug manufacturers, and about the market opportunities for biosimilar drugs in Canada.

This interview is available for download. You can read it right now by clicking here.

As we all know, Korean biologics manufacturers are eyeing the North American market. While Dennis Chan gives us an understanding into activities in this region, other leading industry experts will share first-hand information on Korea's biologics industry at Biologics World Korea taking place from 16-18 April 2013 in Seoul. For the extensive list of speakers and details on the conference program, please download the brochure here.

I hope you enjoy reading the interview!

Best regards,
Natasha Jiandani
Marketing Manager
natasha.jiandani@imapac.com
Tel: +65 9389 4748
Fax: +65 6270 2792
Website: www.imapac.com

P.S.: Delegate passes are going fast, with limited seats remaining. To avoid disappointment, register now!